FDA approves SAGE Therapeutics' (SAGE) treatment for post-partum depression
Go back to FDA approves SAGE Therapeutics' (SAGE) treatment for post-partum depression| Sagebrush Gold Ltd. (NASDAQ: SAGE) | Delayed: 13.58 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.58 | 52 Week High | $62.64 | |||
| Open | $13.58 | 52 Week Low | $26.28 | |||
| Day High | $13.58 | P/E | N/A | |||
| Day Low | $13.58 | EPS | $-0.94 | |||
| Volume | 1 | |||||
